Darrin Beaupre - Dec 9, 2022 Form 3 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
SVP, Chief Medical Officer
Signature
/s/ Jason Throne, as Attorney-in-Fact for Darrin Beaupre
Stock symbol
IDYA
Transactions as of
Dec 9, 2022
Transactions value $
$0
Form type
3
Date filed
12/14/2022, 03:34 PM
Next filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IDYA Stock Option (right to buy) Dec 9, 2022 Common Stock 180K $17.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from November 21, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney